RYDAPT 25 MG CAP MOLE CT BL AL AL X 112
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1006811560011 -
GGREM
526518080094101 -
Código de barras
7896261020900
O que a fonte publica
- Detentor do registro
- NOVARTIS BIOCIENCIAS S.A
- Princípios ativos
- MIDOSTAURINA
- Embalagem
- 25 MG CAP MOLE CT BL AL AL X 112
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Novo
- Classe terapêutica
- L1H9 - OUTROS ANTINEOPLÁSICOS INIBIDORES DA PROTEÍNA KINASE
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "RYDAPT 25 MG CAP MOLE CT BL AL AL X 112",
"holder": "NOVARTIS BIOCIENCIAS S.A",
"stripe": "Tarja Vermelha",
"barcodes": [
"7896261020900"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "526518080094101",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "56.994.502/0001-30",
"priceRegime": "Regulado",
"productName": "RYDAPT",
"productType": "Novo",
"hospitalOnly": false,
"presentation": "25 MG CAP MOLE CT BL AL AL X 112",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "82408.06",
"icms-12": "93645.55",
"icms-17": "99286.80",
"icms-18": "100497.62",
"icms-19": "101738.35",
"icms-20": "103010.08",
"icms-21": "104314.02",
"icms-22": "105651.34",
"icms-23": "107023.43",
"icms-17.5": "99888.54",
"icms-19.5": "102370.26",
"icms-20.5": "103657.97",
"icms-22.5": "106333.02",
"icms-12-alc": "83612.12",
"icms-17-alc": "88648.90",
"icms-18-alc": "89730.02",
"icms-19-alc": "90837.75",
"icms-20-alc": "91973.25",
"icms-21-alc": "93137.51",
"icms-22-alc": "94331.52",
"icms-23-alc": "95556.60",
"withoutTaxes": "73578.61",
"icms-17.5-alc": "89186.21",
"icms-19.5-alc": "91401.99",
"icms-20.5-alc": "92551.67",
"icms-22.5-alc": "94940.10"
},
"pisCofinsList": "Negativa",
"substanceText": "MIDOSTAURINA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "110547.48",
"icms-12": "125622.17",
"icms-17": "133189.71",
"icms-18": "134813.98",
"icms-19": "136478.37",
"icms-20": "138184.35",
"icms-21": "139933.54",
"icms-22": "141727.51",
"icms-23": "143568.12",
"icms-17.5": "133996.92",
"icms-19.5": "137326.06",
"icms-20.5": "139053.48",
"icms-22.5": "142641.96",
"icms-12-alc": "115588.85",
"icms-17-alc": "122551.90",
"icms-18-alc": "124046.49",
"icms-19-alc": "125577.86",
"icms-20-alc": "127147.62",
"icms-21-alc": "128757.14",
"icms-22-alc": "130407.79",
"icms-23-alc": "132101.39",
"withoutTaxes": "101718.12",
"icms-17.5-alc": "123294.70",
"icms-19.5-alc": "126357.89",
"icms-20.5-alc": "127947.25",
"icms-22.5-alc": "131249.12"
},
"invalidBarcodes": [],
"activeSubstances": [
"MIDOSTAURINA"
],
"therapeuticClass": "L1H9 - OUTROS ANTINEOPLÁSICOS INIBIDORES DA PROTEÍNA KINASE",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1006811560011",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "L1H9",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:526518080094101"